journal
MENU ▼
Read by QxMD icon Read
search

Future Microbiology

journal
https://www.readbyqxmd.com/read/27883288/corrigendum
#1
(no author information available yet)
No abstract text is available yet for this article.
November 24, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27838923/contemporary-infectious-exanthems-an-update
#2
Francesco Drago, Giulia Ciccarese, Giulia Gasparini, Ludovica Cogorno, Sanja Javor, Antonio Toniolo, Francesco Broccolo
An exanthem is a skin rash that may be associated with mucous membrane eruption, fever or other symptoms. It may develop as manifestation of an infectious disease or as adverse reaction to drugs. Beside the 'classical exanthems' commonly occurring in childhood, other exanthems, defined as 'atypical' for the different morphology and causal agents, may occur. Among the atypical exanthems with infectious etiology, viral, bacterial, parasitic and helminth infections are implicated. We describe herein etiology and epidemiology of the atypical exanthems caused by infectious agents...
November 14, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27831765/zika-control-through-the-bacterium-wolbachia-pipientis
#3
Eric P Caragata, Heverton Lc Dutra, Scott L O'Neill, Luciano A Moreira
No abstract text is available yet for this article.
November 10, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27831749/crispr-cas-loci-profiling-of-cronobacter-sakazakii-pathovars
#4
Pauline Ogrodzki, Stephen James Forsythe
AIM:  Cronobacter sakazakii sequence types 1, 4, 8 and 12 are associated with outbreaks of neonatal meningitis and necrotizing enterocolitis infections. However clonality results in strains which are indistinguishable using conventional methods. This study investigated the use of clustered regularly interspaced short palindromic repeats (CRISPR)-cas loci profiling for epidemiological investigations. MATERIALS & METHODS: Seventy whole genomes of C. sakazakii strains from four clonal complexes which were widely distributed temporally, geographically and origin of source were profiled...
November 10, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27831742/the-potential-benefits-of-a-new-poliovirus-vaccine-for-long-term-poliovirus-risk-management
#5
Radboud J Duintjer Tebbens, Kimberly M Thompson
AIM: To estimate the incremental net benefits (INBs) of a hypothetical ideal vaccine with all of the advantages and no disadvantages of existing oral and inactivated poliovirus vaccines compared with current vaccines available for future outbreak response. METHODS: INB estimates based on expected costs and polio cases from an existing global model of long-term poliovirus risk management. RESULTS: Excluding the development costs, an ideal poliovirus vaccine could offer expected INBs of US$1...
November 10, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27831741/mechanisms-of-mycobacterial-transmission-how-does-mycobacterium-tuberculosis-enter-and-escape-from-the-human-host
#6
Michael U Shiloh
No abstract text is available yet for this article.
November 10, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27831740/lipidated-%C3%AE-lactamases-from-bench-to-bedside
#7
Lisandro J González, Guillermo Bahr, Alejandro J Vila
No abstract text is available yet for this article.
November 10, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27774799/corrigendum
#8
(no author information available yet)
No abstract text is available yet for this article.
October 24, 2016: Future Microbiology
https://www.readbyqxmd.com/read/27997247/welcome-to-volume-12-of-the-journal-future-microbiology
#9
Frances Adlam
No abstract text is available yet for this article.
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27983878/foodborne-enterotoxigenic-escherichia-coli-from-gut-pathogenesis-to-new-preventive-strategies-involving-probiotics
#10
Charlène Roussel, Adeline Sivignon, Tom Van de Wiele, Stéphanie Blanquet-Diot
Enterotoxigenic Escherichia coli (ETEC) are a major cause of traveler's diarrhea and infant mortality in developing countries. Given the rise of antibiotic resistance worldwide, there is an urgent need for the development of new preventive strategies. Among them, a promising approach is the use of probiotics. Although many studies, mostly performed under piglet digestive conditions, have shown the beneficial effects of probiotics on ETEC by interfering with their survival, virulence or adhesion to mucosa, underlying mechanisms remain unclear...
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27936929/daptomycin-use-where-is-the-truth
#11
Guillaume Ghislain Aubin, Colin Deschanvres, David Boutoille, Pierre Abgueguen, Stéphane Corvec, Jocelyne Caillon, Didier Lepelletier, Frédéric Moal, Dominique Navas
No abstract text is available yet for this article.
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27936923/evaluation-of-the-automated-becton-dickinson-max-real-time-pcr-platform-for-detection-of-pneumocystis-jirovecii
#12
Jung-Yien Chien, Chia-Jung Liu, Pei-Chien Chuang, Tai-Fen Lee, Yu-Tsung Huang, Chun-Hsing Liao, Chien-Ching Hung, Wan-Huei Sheng, Chong-Jen Yu, Po-Ren Hsueh
AIM: We evaluated the performance of the automated quantitative BD MAX (Becton Dickinson) real-time PCR platform for detecting Pneumocystis jirovecii. MATERIALS & METHODS: A total of 34 retrospective and 137 prospective samples were included. RESULTS: Retrospectively, all (100%) positive samples were correctly detected by this platform compared with a nested PCR. Among prospective samples, the overall sensitivity, specificity, positive likelihood ratio and negative likelihood ratio were 92...
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27936910/corrigendum
#13
(no author information available yet)
No abstract text is available yet for this article.
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27922754/daptomycin-use-where-is-the-truth-authors-response
#14
Daniel Echeverría-Esnal, Santiago Grau, Juan Pablo Horcajada
No abstract text is available yet for this article.
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27922753/loss-of-immune-control-in-hiv-infected-patients-how-does-mucosal-candidiasis-occur
#15
Sarah Auclair, Fengliang Liu, Haitao Hu
No abstract text is available yet for this article.
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27922750/pre-implementation-guidelines-for-infectious-disease-point-of-care-testing-in-medical-institutions
#16
Annemiek A van der Eijk, Andrei N Tintu, John P Hays
Infectious disease point-of-care test (ID-POCT) devices are becoming widely available, and in this respect, international quality standards and guidelines are available for consultation once ID-POCT has been implemented into medical institutions. However, specific guidelines for consultation during the initial pre-implementation decision-making process are currently lacking. Further, there exist pre-implementation issues specific to ID-POCT. Here we present pre-implementation guidelines for consultation when considering the implementation of ID-POCT in medical institutions...
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27922746/plant-extracts-initial-screening-identification-of-bioactive-compounds-and-effect-against-candida-albicans-biofilms
#17
Fernanda Lourenção Brighenti, Marcos José Salvador, Aline Vidal Lacerda Gontijo, Alberto Carlos Botazzo Delbem, Ádina Cléia Botazzo Delbem, Cristina Pacheco Soares, Maria Alcionéia Carvalho de Oliveira, Camila Miorelli Girondi, Cristiane Yumi Koga-Ito
AIM: This study screened plants from Brazilian Pantanal for Candida albicans antibiofilm activity. MATERIAL & METHODS: Sixty extracts were obtained from ten plants using different extraction methods. Antifungal activity was assessed. Effects on biofilm inhibition and disruption and cytotoxicity were also evaluated. The most active extract was chemically characterized. RESULTS:  Buchenavia tomentosa ethanolic extract showed noticeable antifungal activity and was selected for biofilm experiments...
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27922745/optimization-of-linezolid-treatment-regimens-for-gram-positive-bacterial-infections-based-on-pharmacokinetic-pharmacodynamic-analysis
#18
Minjie Yang, Jing Zhang, Yuancheng Chen, Xiaoyu Liang, Yan Guo, Jicheng Yu, Demei Zhu, Yingyuan Zhang
AIM: To optimize linezolid treatment regimens for Gram-positive bacterial infections based on pharmacokinetic/pharmacodynamic analysis. MATERIALS & METHODS: The minimum inhibitory concentration (MIC) distribution of 572 Gram-positive strains from patients with clinically confirmed infections was analyzed. Using the Monte Carlo simulation method, the cumulative fraction of response and probability of target attainment were determined for linezolid regimens of 600 mg q...
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27689684/understanding-protein-glycosylation-pathways-in-bacteria
#19
Hong Li, Aleksandra W Debowski, Tingting Liao, Hong Tang, Hans-Olof Nilsson, Barry J Marshall, Keith A Stubbs, Mohammed Benghezal
Through advances in analytical methods to detect glycoproteins and to determine glycan structures, there have been increasing reports of protein glycosylation in bacteria. In this review, we summarize the known pathways for bacterial protein glycosylation: lipid carrier-mediated 'en bloc' glycosylation; and cytoplasmic stepwise protein glycosylation. The exploitation of bacterial protein glycosylation systems, especially the 'mix and match' of three independent but similar pathways (oligosaccharyltransferase-mediated protein glycosylation, lipopolysaccharide and peptidoglycan biosynthesis) in Gram-negative bacteria for glycoengineering recombinant glycoproteins is also discussed...
January 2017: Future Microbiology
https://www.readbyqxmd.com/read/27855500/treatment-of-hepatitis-b-virus-an-update
#20
Haley Ward, Lydia Tang, Bhawna Poonia, Shyam Kottilil
Chronic hepatitis B virus infection is a global health concern as it affects over 240 million people worldwide and an estimated 686,000 people die annually as a result of complications of the disease. With the development of newer antiviral drugs, viral suppression of HBV is achievable, however elimination of HBV from infected individuals (functional cure) remains an issue. Due to persistence of HBV DNA (cccDNA) in infected cells, chronically infected patients who discontinue therapy prior to HBsAg loss or seroconversion are likely to relapse...
December 2016: Future Microbiology
journal
journal
41395
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"